Approval · Notice of Compliance 19976 · 2017
ZOPICLONE: Notice of Compliance 19976
Issued October 30, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19976
- Date
- October 30, 2017
- Company
- Altamed PharmaBoucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Licensing agreement between two companies
- Canadian reference product
- IMOVANE (Sanofi-Aventis Canada Inc.)